Bio/Pharma News

International Federation of Pharmaceutical Manufacturers and Associations takes global action to improve public health.

The US Agency for International Development, the government of Norway, the Bill and Melinda Gates Foundation, Grand Challenges Canada, and The World Bank partner to bring innovative solutions to improve maternal and children’s health in the developing world.

NIH leads new international consortium to develop a diagnostic tool for most known rare diseases by the year 2020.

GSK Works in Developing Nations to Improve Everything from Research to Roads.

The World Health Assembly, the decision-making body of the World Health Organization, met in Geneva last month to discuss and take action on initiatives relating to influenza pandemic preparedness, noncommunicable diseases, and the health-related UN Millennium Development Goals.

Eduardo Pisani, director general of the International Federation of Pharmaceutical Manufacturers & Associations, discusses the global health initiatives and related activities of the association.

A Focus on Creative Strategies to Help the Developing World.

This article, which focuses on distribution and administration, is Part III of a three-part series on biopharmaceutical issues in public health, government, and developing-world markets.

Efforts are made to educate health workers in less developed countries.

The Women in the World Summit, which was held in New York in March, focused on issues and solutions for improving the economic, political, and social rights of women globally, including a focus on global health initiatives.

Eli Lilly and GlaxoSmithKline are among several pharmaceutical companies using technology transfer as way to improve health outcomes in the developing world.

This article, which focuses on manufacturing and drug access, is Part II of a three-part series on biopharmaceutical issues in public health, government, and developing world markets.

PRTM helps to improve supply-chain management and logistics in developing countries.

FDA's efforts to improve access to treatments for rare diseases.

Bristol-Myers Squibb opens a new pediatric HIV/AIDS clinic in Tanzania.

This article is Part I of a three-part series on biopharmaceutical issues in public health, government, and developing-world markets. Part 1 focuses on drug-development. Part II, which examines manufacturing, appeared in the April 2011 of Sourcing and Management. Part III, which analyzes distribution and administration,appeared in the May 2011 issue.

The Novartis Foundation for Sustainable Development held a symposium in December 2010 to continue dialogue on how the private and public sector can work together in achieving the UN Millennium Development Goals.

USP helps to improve drug quality in 32 countries.

One year following the earthquake in Haiti, the pharmaceutical industry and private sector participate in efforts for long-term relief.

The Global Health Progress collaboration works to improve healthcare delivery in the developing world.

Tiered pricing is used throughout industry to help increase affordability and access to drugs in the developing world.

The prevention and treatment of noncommunicable diseases is becoming an increasingly important consideration in global health initiatives.

Merck and AstraZeneca Tackle Cervical Cancer and Tuberculosis.

A look at MVI's malaria work in developing countries.

Industry efforts toward global healthcare surpass average expectations.

An upcoming summit will assess the progress and gaps in realizing the UN Millennium Development Goals, including outcomes from global health initiatives.

Secretary of State Hillary Clinton details the progress and future direction of the US role in the Global Health Initiative.

AAPS President offers hope and solutions for the industry's challenging future.